Published in Arch Ophthalmol on November 01, 1997
Optical coherence tomography of the vitreoretinal interface in macular hole formation. Br J Ophthalmol (2001) 1.29
Idiopathic full thickness macular hole: natural history and pathogenesis. Br J Ophthalmol (2001) 1.00
Visual and anatomical results of surgery for long standing macular holes. Br J Ophthalmol (2000) 0.93
Macular hole opercula: ultrastructural features and clinicopathologic correlation. Arch Ophthalmol (1998) 0.84
Regeneration of the retina: toward stem cell therapy for degenerative retinal diseases. BMB Rep (2015) 0.80
[Macular hole. Survey and relevant surgical concepts]. Ophthalmologe (2005) 0.79
Macular pigment levels following successful macular hole surgery. Br J Ophthalmol (2005) 0.75
Determination of macular hole size in relation to individual variabilities of fovea morphology. Eye (Lond) (2015) 0.75
Photoreceptor Outer Segment on Internal Limiting Membrane after Macular Hole Surgery: Implications for Pathogenesis. Case Rep Ophthalmol (2015) 0.75
25th RCOphth Congress, President's Session paper: 25 years of progress in vitreoretinal surgery. Eye (Lond) (2014) 0.75
An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res (2001) 8.38
Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet (2001) 5.57
Corticobasal degeneration. Brain (1989) 3.20
Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat Genet (2000) 3.00
Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy : Results from a randomized, double-blind, controlled clinical trial. Ophthalmology (2001) 2.83
Neuronal loss in the frontal cortex in HIV infection. Lancet (1991) 2.71
Recognition of vitreoschisis in proliferative diabetic retinopathy. A useful landmark in vitrectomy for diabetic traction retinal detachment. Ophthalmology (1996) 2.36
Simple retinal detachments: identifying the at-risk case. Eye (Lond) (2002) 2.26
Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. Neuroreport (1996) 2.18
Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol (2000) 1.73
Prophylactic argon laser retinopexy prior to removal of silicone oil: a pilot study. Eye (Lond) (1997) 1.67
The epidemiology of rhegmatogenous retinal detachment: geographical variation and clinical associations. Br J Ophthalmol (2009) 1.60
Silicone oil removal. II. Operative and postoperative complications. Br J Ophthalmol (1987) 1.58
Reversed self-sealing pars plana sclerotomies. Retina (2000) 1.57
Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye (Lond) (2007) 1.55
Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy. Gene Ther (2005) 1.48
Pneumatic retinopexy in the treatment of primary rhegmatogenous retinal detachment. Eye (Lond) (1999) 1.47
The use of corticosteroids for choroidal neovascularisation in young patients. Eye (Lond) (1998) 1.43
Silicone oil concentrates fibrogenic growth factors in the retro-oil fluid. Br J Ophthalmol (2004) 1.43
Cataract extraction following vitrectomy and silicone oil tamponade. Eye (Lond) (1995) 1.41
Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy. Ophthalmology (2007) 1.40
High frequency of persistent hyperplastic primary vitreous and cataracts in p53-deficient mice. Cell Death Differ (1998) 1.38
Surgical removal of choroidal neovascular membranes after laser photocoagulation for diabetic maculopathy. Eye (Lond) (2001) 1.38
Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation. Br J Ophthalmol (1996) 1.35
How to predict proliferative vitreoretinopathy: a prospective study. Ophthalmology (2001) 1.33
Animal models of retinal detachment and reattachment: identifying cellular events that may affect visual recovery. Eye (Lond) (2002) 1.31
Scleral-fixated posterior chamber intraocular lenses in non-vitrectomized eyes. Eye (Lond) (2006) 1.31
The longstanding MS lesion. A quantitative MRI and electron microscopic study. Brain (1991) 1.30
Silicone oil removal. I. The effect on the complications of silicone oil. Br J Ophthalmol (1987) 1.30
Visual field loss following vitrectomy for stage 2 and 3 macular holes. Br J Ophthalmol (1996) 1.25
Systemic risk factors for idiopathic macular holes: a case-control study. Eye (Lond) (1998) 1.25
Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy. Br J Ophthalmol (2000) 1.24
Macular microholes: pathogenesis and natural history. Br J Ophthalmol (2005) 1.22
Late onset vitreoretinal complications of regressed retinopathy of prematurity. Br J Ophthalmol (2004) 1.16
Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa. Br J Ophthalmol (1998) 1.14
Repeated injections of a ciliary neurotrophic factor analogue leading to long-term photoreceptor survival in hereditary retinal degeneration. Invest Ophthalmol Vis Sci (1999) 1.14
Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry (1989) 1.14
Three-dimensional structure of the vertebrate muscle A-band. III. M-region structure and myosin filament symmetry. J Mol Biol (1981) 1.12
Soluble TNF receptors in vitreoretinal proliferative disease. Invest Ophthalmol Vis Sci (2001) 1.11
Neuronal number and volume alterations in the neocortex of HIV infected individuals. J Neurol Neurosurg Psychiatry (1993) 1.09
The relationships of age changes in retinal pigment epithelium and Bruch's membrane. Invest Ophthalmol Vis Sci (1999) 1.09
Migrating scleral explants. Eye (Lond) (1992) 1.07
Retinitis pigmentosa and retinal neovascularization. Ophthalmology (1986) 1.06
Inflammatory cells in proliferative vitreoretinopathy subretinal membranes. Ophthalmology (1993) 1.05
Visual function and quality of life following vitrectomy and epiretinal membrane peel surgery. Br J Ophthalmol (2006) 1.04
Vanishing retinal arterial aneurysms: a case report. Br J Ophthalmol (1992) 1.01
Corneal astigmatism following cataract extraction. Br J Ophthalmol (1986) 1.01
Angiopoietin concentrations in diabetic retinopathy. Br J Ophthalmol (2005) 1.01
The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio. Magn Reson Med (1993) 1.00
A prospective study of the effect of a unilateral macular hole on sensory and motor binocular function and recovery following successful surgery. Br J Ophthalmol (2004) 1.00
TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy. Invest Ophthalmol Vis Sci (2000) 0.99
Familial Alzheimer's disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology. Neurosci Lett (1992) 0.99
Combined pars plana vitrectomy and sutured posterior chamber implant. Arch Ophthalmol (2000) 0.99
Biofilm on scleral explants with and without clinical infection. Retina (1999) 0.99
Influence of prior growth conditions on low nutrient response of Escherichia coli in seawater. Can J Microbiol (1989) 0.99
Matrix metalloproteinase biology applied to vitreoretinal disorders. Br J Ophthalmol (2000) 0.98
Variability in the content of Indian generic ciprofloxacin eye drops. Br J Ophthalmol (2005) 0.97
Removal of silicone oil following diabetic vitrectomy. Br J Ophthalmol (1993) 0.97
Correlation of MRI and neuropathology in AIDS. J Neurol Neurosurg Psychiatry (1997) 0.96
Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated. Biochem J (1991) 0.94
Pars plana vitrectomy and sutured posterior chamber lens implantation. Curr Opin Ophthalmol (2001) 0.94
Fundus autofluorescence in patients with macular holes imaged with a laser scanning ophthalmoscope. Br J Ophthalmol (1998) 0.94
Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye (Lond) (2008) 0.93
A prion disease with a novel 96-base pair insertional mutation in the prion protein gene. Neurology (1996) 0.93
Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy. Eye (Lond) (2006) 0.93
Growth factors in proliferative vitreoretinopathy. Br J Ophthalmol (1998) 0.93
Surgical treatment of full-thickness macular holes using autologous serum. Eye (Lond) (1996) 0.93
Visual and anatomical results of surgery for long standing macular holes. Br J Ophthalmol (2000) 0.93
Incidence of idiopathic full-thickness macular holes in fellow eyes. A 5-year prospective natural history study. Ophthalmology (1998) 0.92
Routine use of topical cyclopentolate as a predisposing factor to recurrent urinary tract infections in a susceptible adult. Eye (Lond) (2013) 0.90
Kinetics of transgene expression in mouse retina following sub-retinal injection of recombinant adeno-associated virus. Vision Res (2002) 0.89
Laser treatment of retinal angiomatosis. Eye (Lond) (1989) 0.89
Norrie disease and peripheral venous insufficiency. Br J Ophthalmol (2004) 0.89
Vitrectomy and radial optic neurotomy for central retinal vein occlusion: effects on visual acuity and macular anatomy. Graefes Arch Clin Exp Ophthalmol (2004) 0.89
Two unusual osteogenic orbital tumors: presumed parosteal osteosarcomas of the orbit. Ophthalmology (2001) 0.88
Acute full-thickness macular hole after uncomplicated phacoemulsification cataract surgery. Am J Ophthalmol (2001) 0.88
Retained intravitreal lens fragments after phacoemulsification: a clinicopathological correlation. Br J Ophthalmol (1999) 0.88
Vitreous amyloidosis in alanine 71 transthyretin mutation. Br J Ophthalmol (2005) 0.88
Beta A4 deposition in the temporal cortex of adults with Down's syndrome. J Neurol Sci (1992) 0.88
Electroretinographic changes after vitrectomy and intraocular tamponade. Retina (1985) 0.87
Symmetry of disciform scars in bilateral age-related macular degeneration. Br J Ophthalmol (1991) 0.87
Giant retinal tear and retinal detachment with underlying retinitis pigmentosa and hearing loss. Eye (Lond) (1996) 0.87
The surgical management of uveal effusion syndrome. Eye (Lond) (1987) 0.86
Structure of abnormal molecular assemblies (collagen VI) associated with human full thickness macular holes. J Struct Biol (2000) 0.86
Retinal detachment neuropathology and potential strategies for neuroprotection. Surv Ophthalmol (2005) 0.86
Multifocal choroiditis: clinicopathologic correlation. Arch Ophthalmol (1998) 0.86
The effect of pars plana vitrectomy in the management of Fuchs heterochromic cyclitis. Retina (2001) 0.85
Membranectomy and autologous serum for the retreatment of full-thickness macular holes. Arch Ophthalmol (1997) 0.85
Maintenance of the integrity of the blood-brain barrier in the rat during an in situ saline-based perfusion. Neurosci Lett (1985) 0.85
Differential immunoreactivity of melanocytic lesions of the conjunctiva. Histopathology (2001) 0.85
Delayed suprachoroidal haemorrhage after glaucoma operations. Eye (Lond) (1989) 0.85